BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 30142564)

  • 21. Acetamide Derivatives of Chromen-2-ones as Potent Cholinesterase Inhibitors.
    Prasad S; Kumar B; Kumar S; Chand K; Kamble SS; Gautam HK; Sharma SK
    Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28699213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholinesterase Inhibitory Activity of Some semi-Rigid Spiro Heterocycles: POM Analyses and Crystalline Structure of Pharmacophore Site.
    Hadda TB; Talhi O; Silva ASM; Senol FS; Orhan IE; Rauf A; Mabkhot YN; Bachari K; Warad I; Farghaly TA; Althagafi II; Mubarak MS
    Mini Rev Med Chem; 2018; 18(8):711-716. PubMed ID: 28714400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular modeling and in vitro approaches towards cholinesterase inhibitory effect of some natural xanthohumol, naringenin, and acyl phloroglucinol derivatives.
    Orhan IE; Jedrejek D; Senol FS; Salmas RE; Durdagi S; Kowalska I; Pecio L; Oleszek W
    Phytomedicine; 2018 Mar; 42():25-33. PubMed ID: 29655693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis and pharmacological evaluation of chalcone derivatives as acetylcholinesterase inhibitors.
    Liu HR; Liu XJ; Fan HQ; Tang JJ; Gao XH; Liu WK
    Bioorg Med Chem; 2014 Nov; 22(21):6124-33. PubMed ID: 25260958
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis, in vitro assay, and molecular modeling of new piperidine derivatives having dual inhibitory potency against acetylcholinesterase and Abeta1-42 aggregation for Alzheimer's disease therapeutics.
    Kwon YE; Park JY; No KT; Shin JH; Lee SK; Eun JS; Yang JH; Shin TY; Kim DK; Chae BS; Leem JY; Kim KH
    Bioorg Med Chem; 2007 Oct; 15(20):6596-607. PubMed ID: 17681794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Boltneva NP; Serebryakova OG; Rudakova EV; Ustyugov AA; Bachurin SO; Shchepochkin AV; Chupakhin ON; Charushin VN; Richardson RJ
    Bioorg Med Chem; 2017 Nov; 25(21):5981-5994. PubMed ID: 28986116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and Evaluation of the 4-Substituted 2-Hydroxy-5-Iodochalcones and Their 7-Substituted 6-Iodoflavonol Derivatives for Inhibitory Effect on Cholinesterases and β-Secretase.
    Mphahlele MJ; Agbo EN; Gildenhuys S
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567381
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and cholinesterase inhibitory activity study of new piperidone grafted spiropyrrolidines.
    Basiri A; Abd Razik BM; Ezzat MO; Kia Y; Kumar RS; Almansour AI; Arumugam N; Murugaiyah V
    Bioorg Chem; 2017 Dec; 75():210-216. PubMed ID: 28987876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies.
    Korabecny J; Dolezal R; Cabelova P; Horova A; Hruba E; Ricny J; Sedlacek L; Nepovimova E; Spilovska K; Andrs M; Musilek K; Opletalova V; Sepsova V; Ripova D; Kuca K
    Eur J Med Chem; 2014 Jul; 82():426-38. PubMed ID: 24929293
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined molecular modeling and cholinesterase inhibition studies on some natural and semisynthetic O-alkylcoumarin derivatives.
    Orhan IE; Senol Deniz FS; Salmas RE; Durdagi S; Epifano F; Genovese S; Fiorito S
    Bioorg Chem; 2019 Mar; 84():355-362. PubMed ID: 30530106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, preliminarily biological evaluation and molecular docking study of new Olaparib analogues as multifunctional PARP-1 and cholinesterase inhibitors.
    Gao CZ; Dong W; Cui ZW; Yuan Q; Hu XM; Wu QM; Han X; Xu Y; Min ZL
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):150-162. PubMed ID: 30427217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis, biological evaluation and docking studies of 2,3-dihydroquinazolin-4(1H)-one derivatives as inhibitors of cholinesterases.
    Sarfraz M; Sultana N; Rashid U; Akram MS; Sadiq A; Tariq MI
    Bioorg Chem; 2017 Feb; 70():237-244. PubMed ID: 28126287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tetrahydroquinoline-Isoxazole/Isoxazoline Hybrid Compounds as Potential Cholinesterases Inhibitors: Synthesis, Enzyme Inhibition Assays, and Molecular Modeling Studies.
    Rodríguez Núñez YA; Gutíerrez M; Alzate-Morales J; Adasme-Carreño F; Güiza FM; Bernal CC; Bohórquez ARR
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31861333
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, Synthesis, and Biological Evaluation of Novel Indanone Derivatives as Cholinesterase Inhibitors for Potential Use in Alzheimer's Disease.
    Etemadi A; Hemmati S; Shahrivar-Gargari M; Abibiglue YT; Bavili A; Hamzeh-Mivehroud M; Dastmalchi S
    Chem Biodivers; 2023 Aug; 20(8):e202300075. PubMed ID: 37458518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyridine sulfonamide as a small key organic molecule for the potential treatment of type-II diabetes mellitus and Alzheimer's disease: In vitro studies against yeast α-glucosidase, acetylcholinesterase and butyrylcholinesterase.
    Riaz S; Khan IU; Bajda M; Ashraf M; Qurat-Ul-Ain ; Shaukat A; Rehman TU; Mutahir S; Hussain S; Mustafa G; Yar M
    Bioorg Chem; 2015 Dec; 63():64-71. PubMed ID: 26451651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and Biological Evaluation of New Cholinesterase Inhibitors for Alzheimer's Disease.
    Hussein W; Sağlık BN; Levent S; Korkut B; Ilgın S; Özkay Y; Kaplancıklı ZA
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30110946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis of novel 1,2,3 triazole derivatives and assessment of their potential cholinesterases, glutathione S-transferase enzymes inhibitory properties: An in vitro and in silico study.
    Çelik F; Türkan F; Aras A; Atalar MN; Karaman HS; Ünver Y; Kahriman N
    Bioorg Chem; 2021 Feb; 107():104606. PubMed ID: 33476865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics and molecular docking studies of loganin, morroniside and 7-O-galloyl-D-sedoheptulose derived from Corni fructus as cholinesterase and β-secretase 1 inhibitors.
    Bhakta HK; Park CH; Yokozawa T; Min BS; Jung HA; Choi JS
    Arch Pharm Res; 2016 Jun; 39(6):794-805. PubMed ID: 27106028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholinesterase inhibitory activity of chlorophenoxy derivatives-Histamine H3 receptor ligands.
    Łażewska D; Jończyk J; Bajda M; Szałaj N; Więckowska A; Panek D; Moore C; Kuder K; Malawska B; Kieć-Kononowicz K
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4140-5. PubMed ID: 27445168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis and preliminary structure-activity relationship investigation of nitrogen-containing chalcone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors: a further study based on Flavokawain B Mannich base derivatives.
    Liu H; Fan H; Gao X; Huang X; Liu X; Liu L; Zhou C; Tang J; Wang Q; Liu W
    J Enzyme Inhib Med Chem; 2016 Aug; 31(4):580-9. PubMed ID: 26186269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.